Merck Millipore Revenue and Competitors

USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Merck Millipore's estimated annual revenue is currently $6.9B per year.(i)
  • Merck Millipore's estimated revenue per employee is $201,000

Employee Data

  • Merck Millipore has 34306 Employees.(i)
  • Merck Millipore grew their employee count by 9% last year.

Merck Millipore's People

NameTitleEmail/Phone
1
Co-Founder Merck Innovation CenterReveal Email/Phone
2
Chief Staff & Head CEO Office Life ScienceReveal Email/Phone
3
CFO UK & IrelandReveal Email/Phone
4
CFO Merck Group IsraelReveal Email/Phone
5
CEO, HealthcareReveal Email/Phone
6
Head External Manufacturing - VPReveal Email/Phone
7
Chief StaffReveal Email/Phone
8
CFO Nordic and Baltic StatesReveal Email/Phone
9
CFO Healthcare R&DReveal Email/Phone
10
Executive Assistant to VP, Global Business Excellence & InnovationReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Merck Millipore?

We are Merck, a vibrant science and technology company. \n\nScience is at the heart of everything we do. It drives the discoveries we make and the technologies we create.\n\nThe passion of our curious minds makes a positive difference to millions of people’s lives every day. \n\nIn Healthcare, we discover unique ways to treat the most challenging diseases, such as multiple sclerosis and cancer. Our Life Science experts empower scientists by developing tools and solutions that help deliver breakthroughs more quickly. And in Performance Materials, we develop science that sits inside technologies and changes the way we access, store, process, and display information.\n\nEverything we do is fueled by a belief in science and technology as a force for good. A belief that has driven our work since 1668 and will continue to inspire us to find more joyful and sustainable ways to live.\n\nWe are curious minds dedicated to human progress.\n\nSound like something you'd like to be part of? Explore www.come2merck.com and bring your curiosity to life.\n\nThis channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Performance Materials in Performance Materials. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada.\n\nLegal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html\n\nData Privacy Declaration: www.merckgroup.com/en/privacy-statement

keywords:N/A

N/A

Total Funding

34306

Number of Employees

$6.9B

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Merck Millipore News

2022-04-17 - Human Activin A Market Global Development Analysis 2022 to ...

Merck Millipore; Thermo Fisher Scientific; Bio-Techne; StemRD; Prospec; Proteintech Group; Ajinomoto; Enzo Life Sciences; IBL; STEMCELL...

2022-04-17 - Membrane Separation Technology Market Size And Forecast ...

DOW Chemical Company, Merck Millipore, Nitto Denko Corporation, Toray Industries, Pentair PLC, Asahi Kasei Corporation, Koch Membrane...

2022-04-06 - Epigenetics Market is Going to Boom with Abcam Plc., Merck ...

Merck Millipore; PerkinElmer, Incorporated; QIAGEN N.V.; Thermo Fisher Scientific Incorporated; Zymo Research; Other Prominent Players. Scope of...

2021-11-03 - Merck KGaA raises forecast for full year 2021

DGAP-Ad-hoc: Merck KGaA / Key word(s): Change in Forecast/9 Month figures Merck KGaA raises forecast for full year 2021 03-Nov-2021 / 18:42 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16004.2M351748%N/A
#2
$10487.8M365437%N/A
#3
$300M390525%N/A
#4
$12543.9M39471N/AN/A
#5
$9702.2M3960128%N/A